Analysis

4 Key Moments From J&J's Mesh Marketing Battle With Calif.

By Daniel Siegal (October 2, 2019, 8:41 PM EDT) -- California has just completed a first-of-its-kind trial over Johnson & Johnson unit Ethicon's marketing of its pelvic mesh, but resistant witnesses and dueling doctors may spell long odds for convincing a state court judge to rule that the pharma giant deceived Golden State patients and must pay $800 million in penalties.

During the eight-week bench trial, California Attorney General Xavier Becerra accused J&J and Ethicon of lying to Golden State consumers and doctors about the safety of two lines of mesh products: tension-free vaginal tape, or TVT, launched in 1998 to treat stress urinary incontinence, and the Prolift, launched in 2005...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!